The Cervical Cancer Cell Lines Hela, Siha, and Caski

The Cervical Cancer Cell Lines Hela, Siha, and Caski

The four hypoxia gene lists together with fold-change (Log2-transformed) of expression after hypoxia treatment in the cervical cancer cell lines HeLa, SiHa, and CaSki Hypoxia cervical up x3 Hypoxia cervical up & literature Hypoxia cervical down x3 Hypoxia cervical down & literature GeneSymbol HeLa SiHa CaSki GeneSymbol HeLa SiHa CaSki ABCA7 2.347 2.008 1.036 MLKL -1.298 -1.500 -1.089 ARID3A 1.369 3.040 1.256 NOL6 -2.084 -1.305 -1.543 C1ORF51 1.240 2.139 1.591 NOP2 -1.525 -1.531 -1.060 HIG2 2.781 2.185 2.158 PRMT3 -1.216 -1.084 -1.431 CMIP 1.190 1.003 1.130 ELOVL6 -1.743 -1.557 -1.490 FGF11 1.752 3.849 2.682 HSPH1 -1.796 -1.255 -1.002 FTH1P3 1.135 1.490 1.033 KIAA0020 -1.100 -1.184 -1.148 GPRC5C 1.011 4.025 1.307 LRP8 -1.099 -1.529 -1.248 HSF2BP 1.647 1.020 1.049 ODC1 -1.393 -1.578 -1.796 IRS2 1.552 1.128 1.352 VARS -1.772 -1.076 -1.125 LOC100008589 1.992 2.096 1.120 ABCF2 -1.129 -0.807 -0.725 LOC286016 2.431 1.532 1.232 ACOT7 0.125 -1.300 -0.933 LOC401152 2.016 2.262 1.810 ADAR -1.619 -0.198 -0.102 LOC441763 2.646 2.047 1.127 AIMP2 0.209 -1.330 -0.881 LOC644760 2.284 1.428 1.375 AMD1 -1.484 -0.639 -0.469 LOC644774 1.328 2.036 1.871 ANLN -1.210 -1.560 0.561 LOC645553 2.282 1.658 1.581 ATIC -1.036 -0.738 -0.834 LOC730525 1.548 1.646 1.668 ATP5G1 0.631 -1.445 -1.243 LOC732165 2.843 1.861 1.251 BCS1L -0.075 -1.010 -0.540 MALL 1.368 2.180 1.089 BOP1 -1.145 -0.863 -0.916 NMB 1.868 1.265 1.724 BRCA1 -0.006 -1.101 0.211 NUDT18 1.845 1.444 1.208 C12ORF48 -0.985 -1.219 -0.163 PGAM4 1.674 1.434 1.006 C17ORF80 -1.277 -0.462 -0.183 PIK3IP1 1.100 1.421 1.477 C1ORF135 0.187 -1.500 -0.493 SLPI 2.428 1.183 1.230 C1ORF163 -0.086 -1.042 -0.894 TMEM145 1.029 2.401 1.514 C20ORF27 0.405 -1.387 -0.368 TMEM158 1.044 1.249 1.238 CAD -0.761 -1.093 -0.449 TNNT1 1.835 1.628 1.107 CALD1 -1.040 0.595 0.297 VKORC1 2.453 1.792 1.373 CALM1 -1.207 0.078 0.015 ADM 2.973 2.359 1.489 CAPRIN1 -1.580 -0.417 -0.432 AK3L1 2.063 2.590 1.208 CBX6 -1.918 -0.278 -0.426 ALDOA 1.690 1.475 1.132 CCDC86 -0.680 -0.405 -1.109 ALDOC 4.288 3.918 1.793 CCDC99 -0.432 -1.171 -0.089 ANG 3.058 2.225 2.283 CCNA2 -0.759 -2.159 -0.416 ANKRD37 3.809 3.731 2.380 CCND1 -2.287 -0.046 -1.584 ANKZF1 1.881 1.781 1.406 CCND3 -1.286 -1.117 -0.457 BHLHB2 1.010 1.540 1.752 CCNF -1.695 -1.787 -0.168 BNIP3 3.299 3.392 2.598 CCT6A -1.337 -0.755 -0.723 BNIP3L 2.044 3.613 2.839 CDC2 0.064 -1.654 -0.063 BTG1 1.754 1.455 1.556 CDC20 -0.958 -2.065 -0.514 CA9 5.977 6.104 4.825 CDCA4 0.908 -1.040 0.070 Cervix cancer hypoxia gene sets p1 CCNG2 1.247 1.252 1.149 CENPF -1.248 -1.798 0.016 CDKN1A 1.109 1.595 1.043 CENPN 0.917 -1.019 -0.002 DDIT4 1.750 2.234 3.578 CNOT7 -1.130 0.122 0.031 EGLN1 1.484 1.323 1.307 COL18A1 -1.254 0.106 0.117 EGLN3 1.561 2.161 1.388 CORO1C -1.019 0.396 -0.122 ENO2 2.870 2.553 2.797 CSDE1 -1.096 -0.145 -0.429 ERRFI1 2.967 1.389 2.106 CSE1L -1.255 -1.115 -0.763 FAM162A 2.850 2.294 2.033 CTPS -0.962 -1.048 -0.897 GAPDH 1.072 1.277 1.072 CYTSA -1.050 0.120 0.364 GPI 1.627 1.427 1.374 DDX23 -1.297 -0.695 -0.305 HCFC1R1 2.269 1.333 1.082 DDX3X -1.320 0.261 0.206 HK2 1.782 3.158 1.346 DHCR24 -1.102 -0.517 -0.323 IGFBP3 3.043 3.780 2.288 DHX29 -1.190 -0.536 -0.533 INSIG2 1.831 2.272 2.012 DLAT -1.222 -0.123 -0.482 JMJD1A 1.064 1.763 1.592 EEF2 -1.349 0.669 0.305 KCTD11 1.244 1.842 1.925 EFEMP1 -1.215 -0.783 -0.609 LOX 1.890 4.247 2.822 EFTUD2 -1.033 -0.505 -0.446 MUC1 1.335 2.392 2.193 ERCC6L -0.576 -1.556 -0.357 NDRG1 3.436 3.424 3.953 EXO1 -0.290 -2.210 -0.193 P4HA1 1.870 2.587 2.051 FANCG -0.260 -1.046 -0.127 P4HA2 1.840 2.805 1.544 FANCI -1.087 -1.405 0.175 PFKFB4 2.657 3.671 3.575 FASN -1.587 -0.899 -0.930 PGAM1 1.422 1.527 1.128 FASTKD5 -1.196 -0.539 -0.489 PGK1 1.444 1.986 1.867 FBXO5 0.093 -1.301 0.182 PLOD2 1.456 2.232 2.103 FEN1 0.316 -1.146 -0.151 PPFIA4 2.129 2.214 1.783 FGF2 -1.315 0.002 -0.179 PTPRR 1.281 1.040 1.325 GART -0.728 -1.122 -0.666 RNASE4 2.273 2.595 2.358 GINS3 0.101 -1.234 -0.046 RNF24 1.143 1.574 1.094 GLRX2 0.586 -1.086 -0.081 SH3GL3 1.747 2.739 1.548 GMFB -1.598 -0.047 0.058 SPRY1 1.996 2.727 2.146 GNA13 -1.044 0.237 0.341 STC2 2.540 4.348 2.824 GNPDA1 -1.011 -0.348 -0.765 TMEM45A 3.846 3.741 2.560 GPD1L -1.423 -0.761 -0.754 TPI1 1.617 1.254 1.016 GPR56 -1.196 -0.299 -0.211 VLDLR 1.869 2.711 1.762 GULP1 -1.058 -0.236 -0.196 WDR54 2.383 1.816 1.126 H2AFX 0.771 -1.253 -0.021 YPEL5 1.146 1.687 1.374 HEATR1 -1.799 -0.753 -0.503 ZNF395 2.073 2.886 1.569 HIF1A -1.006 0.596 0.146 ABCA1 -0.566 1.133 1.038 HJURP 0.120 -1.879 -0.078 ABCB6 0.513 1.258 0.975 HMBS 0.457 -1.329 -0.659 ADORA2B 1.560 1.459 -0.602 HSPA1A -1.351 -0.459 -0.610 AK2 1.090 0.429 0.122 HSPA1B -1.255 -0.478 -0.393 ANGPTL4 0.776 3.486 3.613 HSPA4 -1.137 -0.197 -0.328 ANKRD9 1.323 0.985 0.218 HSPC111 0.522 -1.183 -1.208 AOX1 0.728 1.718 -0.006 HSPD1 -1.005 -0.604 -0.761 APITD1 1.096 -0.691 -0.139 HSPE1 -0.209 -0.650 -1.042 ARRDC3 0.009 1.491 1.208 IARS -1.211 -0.657 0.210 ATF3 0.906 0.413 1.158 IDE -1.688 -0.756 -0.574 ATP1B1 1.084 1.413 0.098 IDH3A -1.135 -0.246 -0.920 ATP5O 1.132 -0.005 0.026 KIF23 -1.138 -1.985 -0.259 Cervix cancer hypoxia gene sets p2 AXL -0.567 1.397 0.282 KIF4A -0.425 -1.507 0.195 B3GNT4 0.338 1.955 0.305 KIAA0101 0.967 -1.571 -0.016 BAX 1.735 -0.341 0.300 KIAA0564 -1.168 -0.249 -0.024 BIK 0.651 1.866 1.428 KPNA4 -1.243 -0.268 -0.209 BLVRB 1.053 0.049 0.395 LARP4 -1.457 -0.185 -0.342 BOLA2 1.497 -0.647 -0.404 LARS2 -1.173 -0.350 -0.321 C10ORF10 -0.038 0.142 1.493 LDLR -1.288 -1.117 -0.527 C12ORF24 1.243 1.066 -0.122 LETM1 -1.272 -0.711 -0.283 C14ORF2 1.088 -0.073 -0.307 MAD2L1 0.132 -1.428 -0.372 C16ORF74 1.218 1.213 0.157 MCL1 -1.098 -0.925 -0.564 C19ORF53 1.285 -0.399 -0.252 MCM10 0.290 -1.317 0.082 C3ORF10 1.503 1.172 0.514 MELK 0.047 -1.760 0.152 C5ORF13 0.334 1.683 0.655 MEST -1.412 -0.344 -1.058 CA12 1.678 3.304 0.067 MNS1 0.403 -1.627 -0.342 CAV1 0.841 1.166 0.571 MPHOSPH9 -1.160 -1.078 -0.184 CD99 1.715 0.817 0.275 MRTO4 0.337 -0.766 -1.027 CDC2L6 -0.068 1.102 0.968 NARS -1.019 -0.554 -0.062 CDKN1C 2.384 0.260 0.569 NAT10 -1.292 0.384 -0.703 CEBPB -0.101 0.026 1.001 NCAPG2 -0.380 -1.386 0.149 CEBPD 1.443 0.538 -0.132 NFKB1 -1.400 -0.366 -0.056 CECR5 0.929 1.015 0.189 NME1 0.496 -0.794 -1.216 CFD 2.469 0.979 0.227 NMT1 -1.732 0.027 -0.234 CHSY1 -0.233 1.734 0.291 NOL11 -1.415 -0.646 -0.621 CITED2 1.169 1.802 0.705 NOL12 0.073 -1.151 -0.245 CKB 1.890 0.588 0.008 NOLC1 -1.484 -1.202 -0.683 CNOT8 0.670 1.084 0.522 NOP56 -0.055 -1.156 -0.896 COL5A1 -0.435 1.433 1.274 NUP160 -1.471 -0.682 -0.277 CRLF1 1.139 0.325 -0.179 NUP205 -1.094 -0.659 -0.373 CSNK2B 1.350 -0.076 0.041 NUP85 -0.195 -1.014 -0.050 CSRP2 1.666 0.831 0.877 NUSAP1 -0.421 -1.484 0.059 CXCR4 1.263 -0.103 -0.226 OIP5 0.708 -1.344 -0.251 CXCR7 0.862 1.242 0.019 ORC6L 0.491 -1.937 -0.195 CYB5A 1.006 -0.386 -0.263 PA2G4 0.537 -1.312 -0.524 DDIT3 1.510 0.383 1.210 PARP1 -1.243 -0.107 -0.436 DDX41 0.771 1.371 0.448 PARP2 0.079 -1.158 -0.138 DPM2 1.172 -0.236 -0.081 PBK -0.062 -1.564 -0.500 DPYSL2 0.402 0.634 1.053 PCYT2 -0.138 -1.118 -0.410 DPYSL4 -0.368 2.636 -0.001 PER3 -0.558 -1.166 -0.007 DUSP1 0.912 1.460 0.351 PFAS -1.751 -0.950 -0.896 EBP 1.232 -0.958 0.128 PKMYT1 0.817 -2.080 0.241 EBPL 1.350 0.483 -0.352 POLA2 -0.547 -1.209 -0.064 ECE2 1.042 0.292 -0.382 POLE2 0.201 -1.336 -0.409 EDN2 3.570 4.209 0.234 PPARG -0.776 -1.137 -1.003 EFNA1 0.979 1.167 0.199 PPAT -1.019 -0.274 -0.728 EIF1B 1.146 -0.204 -0.007 PRC1 -0.925 -2.004 0.037 ELF3 0.644 1.000 0.234 PSMC3IP 0.968 -1.311 -0.051 ELL2 -0.211 1.121 0.347 PSME3 -1.137 -0.291 -0.746 EMP3 1.520 0.523 0.130 PSME4 -1.482 -0.209 -0.411 EPOR 1.192 0.579 0.195 PSMG1 0.414 -1.022 -0.234 ERO1L 0.366 1.651 1.200 RAD51AP1 -0.175 -1.706 0.160 Cervix cancer hypoxia gene sets p3 EXOSC8 1.014 -0.851 0.010 RAI14 -1.110 -0.506 -0.564 FABP5 1.064 -0.677 -0.571 RANBP1 0.483 -1.052 -0.555 FAM119B 0.455 2.121 0.188 RANGAP1 -1.780 -1.127 -0.093 FAM13A 0.477 1.480 0.405 RBM12 -1.059 -0.525 -0.595 FAM46A -0.150 0.863 1.220 RFC3 -0.610 -1.683 -0.449 FER1L4 -0.342 1.610 -0.702 RFC5 0.099 -1.121 -0.208 FLNB 0.336 0.889 1.217 RNF14 -1.102 -0.035 0.054 FOS -0.885 1.942 -0.125 RPP40 0.377 -1.140 -1.085 FOXD1 1.943 1.495 0.117 RRM1 -0.622 -1.108 -0.228 FOXO3 0.077 1.109 0.200 RRM2 -0.206 -2.346 -0.141 GADD45B 1.261 0.867 0.701 RRP1B -1.065 0.003 -0.282 GBE1 0.914 2.877 1.318 RRP9 -0.423 -0.799 -1.240 GLRX 1.662 1.357 0.792 RRS1 -0.136 -1.356 -1.362 GLS -0.019 1.196 0.402 SCD -1.111 0.357 0.555 GPRC5A 1.506 1.491 0.762 SEH1L -1.198 -0.338 -0.473 GRSF1 -0.572 1.387 0.104 SEL1L3 -1.208 -0.360 0.279 GYS1 0.988 1.636 0.751 SFRS1 -1.127 -0.649 -0.477 HBP1 0.450 1.129 0.793 SIP1 0.236 -1.039 -0.523 HERC3 0.400 1.098 0.483 SKP2 -0.960 -1.096 -1.221 HERPUD1 1.091 0.650 0.996 SLC11A2 -1.308 0.056 -0.553 HLA-B 1.698 1.426 0.340 SLC25A44 -1.506 -0.335 -0.162 HLA-DQB1 0.023 3.361 0.180 SLC5A6 -1.374 -1.096 -0.822 HLA-DRB1 0.183 2.991 -0.030 SQLE -0.603 -1.022 -0.209 HMHA1 -0.254 1.168 0.880 SRM 0.339 -0.793 -1.180 HMOX1 0.906 1.092 1.799 STIL -1.009 -1.678 0.169 HOMER1 -0.334 1.193 -0.080 TFRC -1.022 0.889 -0.568 HSPA5 -0.478 1.610 -0.014 THBS1 -1.017 0.369 -0.129 ID1 1.720 0.294 -0.424 TIPIN 0.079 -0.888 -1.095 ID2 1.955 0.309 0.528 TMTC3 -1.577 -0.162 -0.211 IDH2 1.901 0.384 0.608 TPX2 -1.318 -2.036 0.195 IER3 2.286 2.491 0.987 TRIOBP 0.040 -1.082 -0.213 IGFBP2 1.066 -0.114 0.108 TRIP13 -0.193 -1.838 -0.554 IGFBP5 1.111 2.282 -0.673 TRMT5 0.064 -1.216 -0.230 IGFBP7 1.311 0.253 0.408 TSEN2 -1.032 -0.775 -1.046 ILVBL 0.189 1.214 0.709 TUBB2C 0.240 -1.179 -0.138 IMMP2L 1.278 0.839 -0.101 TUBG1 0.434 -1.208 -0.149 IMP3 1.238 0.774 0.473 TUBGCP4 -1.057 -0.406 -0.497 INHBE 1.329 0.061 0.094 VWF -1.155 0.167

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    14 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us